$8.42
-0.55-6.13%
In chiusura: -
$8.42
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Olema Pharmaceuticals. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Olema Pharmaceuticals.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Olema Pharmaceuticals inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 18, 2025, Cyrus Harmon, l'azienda - sold 25K condivisioni per $8.19 ciascuna.
Statistiche sulla proprietà per Olema Pharmaceuticals inc
Numero di azioni emesse
68.634M
Azioni possedute dagli insider
3.966M
Percentuale posseduta dagli Insider
5.78%
Azioni possedute dagli investitori istituzionali
25.217M
Percentuale posseduta dagli investitori istituzionali
36.7%
Sep 18, 2025 | — | -25.00K | $8.19 | -$204.84K | SELL | -17.60% | 117.03K | Sep 16 - Sep 18 | ||
Jan 13, 2025 | — | -3.20M | $5.76 | $1.73M | DISPOSITION | -42.67% | 4.30M | Jan 08 - Jan 10 | ||
Dec 17, 2024 | DIRECTOR | -1.40M | $6.75 | -$9.46M | SELL | -49.87% | 1.41M | Dec 17 | ||
Dec 11, 2024 | — | 12.86K | $9.03 | -$147.96K | GRANT | 1.47% | 886.17K | Dec 09 - Dec 11 | ||
Dec 11, 2024 | CH. DISCOV. & NON-CLIN DEV OFF | 22.68K | $9.01 | -$234.92K | GRANT | 3.11% | 753.18K | Dec 09 - Dec 11 | ||
Dec 11, 2024 | CHIEF MEDICAL OFFICER | 24.20K | $9.01 | -$250.46K | GRANT | 26.50% | 115.51K | Dec 09 - Dec 11 | ||
Dec 11, 2024 | CH. OPERATING & FINANCIAL OFF. | 33.09K | $9.01 | -$316.70K | GRANT | 6.48% | 543.55K | Dec 09 - Dec 11 | ||
Dec 11, 2024 | PRESIDENT AND CEO | 95.25K | $9.01 | -$986.37K | GRANT | 65.05% | 241.66K | Dec 09 - Dec 11 | ||
Aug 05, 2024 | 10% OWNER | -2.40M | $14.91 | -$35.80M | SELL | -75.40% | 783.12K | Aug 01 | ||
Jul 31, 2024 | — | -5.00K | $15.57 | -$77.87K | SELL | -0.57% | 873.31K | Jul 29 - Jul 30 | ||
Jul 12, 2024 | — | -5.00K | $12.26 | -$61.30K | SELL | -0.57% | 878.31K | Jul 11 | ||
Jul 02, 2024 | — | -20.00K | $10.77 | -$215.40K | SELL | -2.21% | 883.31K | Jun 28 | ||
Jun 06, 2024 | DIRECTOR | -1.18M | $14.85 | -$17.45M | SELL | -62.40% | 708.11K | Jun 04 | ||
Jun 04, 2024 | — | -25.00K | $10.30 | -$257.45K | SELL | -2.69% | 903.31K | May 31 - Jun 04 | ||
May 07, 2024 | — | -5.00K | $10.92 | -$54.60K | SELL | -0.54% | 928.31K | May 06 | ||
May 02, 2024 | — | -15.00K | $9.51 | -$142.65K | SELL | -1.58% | 933.31K | Apr 30 | ||
Mar 29, 2024 | — | -20.00K | $10.97 | -$219.40K | SELL | -2.07% | 948.31K | Mar 28 | ||
Mar 04, 2024 | — | -25.00K | $12.41 | -$310.31K | SELL | -2.52% | 968.31K | Feb 29 | ||
Feb 02, 2024 | — | -30.00K | $12.79 | -$383.55K | SELL | -2.93% | 993.31K | Jan 31 - Feb 01 | ||
Jan 02, 2024 | — | -25.00K | $13.38 | -$334.50K | SELL | -2.38% | 1.02M | Dec 29 | ||
Dec 18, 2023 | DIRECTOR | 640.00K | $10.74 | $6.87M | BUY | 27.31% | 2.98M | Sep 12 - Dec 05 | ||
Dec 08, 2023 | 10% OWNER | 100.00K | $11.60 | $1.16M | BUY | 1.28% | 7.90M | Dec 06 | ||
Dec 01, 2023 | — | -25.00K | $12.57 | -$314.25K | SELL | -2.33% | 1.05M | Nov 30 | ||
Nov 22, 2023 | — | 7.57K | $14.39 | -$117.74K | GRANT | 0.71% | 1.07M | Nov 20 - Nov 22 | ||
Nov 22, 2023 | CHIEF MEDICAL OFFICER | 13.44K | $14.38 | -$209.30K | GRANT | 78.07% | 30.66K | Nov 20 - Nov 22 | ||
Nov 22, 2023 | CH. DISCOV. & NON-CLIN DEV OFF | 12.62K | $14.40 | -$196.23K | GRANT | 1.76% | 728.95K | Nov 20 - Nov 22 | ||
Nov 22, 2023 | PRESIDENT AND CEO | 53.02K | $14.40 | -$824.13K | GRANT | 57.70% | 144.93K | Nov 20 - Nov 22 | ||
Nov 22, 2023 | CH. OPERATING & FINANCIAL OFF. | 18.01K | $14.39 | -$269.66K | GRANT | 4.42% | 424.99K | Nov 20 - Nov 22 | ||
Nov 13, 2023 | CH. DISCOV. & NON-CLIN DEV OFF | -200.00 | $17.61 | -$3.52K | SELL | -0.03% | 716.12K | Nov 08 | ||
Nov 03, 2023 | CH. DISCOV. & NON-CLIN DEV OFF | -10.54K | $15.26 | -$160.81K | SELL | -1.45% | 716.32K | Nov 01 - Nov 03 | ||
Nov 02, 2023 | — | -30.00K | $12.65 | -$379.45K | SELL | -2.74% | 1.07M | Oct 31 - Nov 02 | ||
Oct 03, 2023 | — | -25.00K | $12.41 | -$310.25K | SELL | -2.23% | 1.10M | Sep 29 | ||
Sep 21, 2023 | CH. DISCOV. & NON-CLIN DEV OFF | -20.00K | $12.67 | -$253.40K | SELL | -2.68% | 726.86K | Sep 19 | ||
Sep 14, 2023 | DIRECTOR | 1.61M | $9.84 | $14.82M | BUY | ∞ | 99.56K | Sep 12 - Sep 14 | ||
Sep 05, 2023 | — | -25.00K | $10.26 | -$256.60K | SELL | -2.18% | 1.12M | Aug 31 - Sep 05 | ||
Aug 17, 2023 | — | -15.00K | $10.14 | -$152.10K | SELL | -1.29% | 1.15M | Aug 16 | ||
Jun 09, 2023 | — | -10.00K | $6.30 | -$63.00K | SELL | -0.85% | 1.16M | Jun 08 | ||
Jun 07, 2023 | — | -10.00K | $6.17 | -$61.70K | SELL | -0.85% | 1.17M | Jun 05 - Jun 06 | ||
Apr 07, 2023 | CH. OPERATING & FINANCIAL OFF. | 10.00K | $0.00 | $0.00 | BUY | 2.59% | 396.20K | Apr 06 | ||
Sep 06, 2022 | CH. OPERATING & FINANCIAL OFF. | 20.00K | $0.00 | $0.00 | BUY | 5.54% | 381.20K | Sep 02 | ||
Jun 14, 2022 | DIRECTOR | 200.00K | $4.03 | $806.90K | BUY | 6.29% | 3.38M | Jun 10 | ||
Mar 14, 2022 | CHIEF BUSINESS OFFICER | 0.00 | $3.41 | -$14.11K | SELL-OPTIONS | 0.00% | 2.46K | Mar 10 | ||
Jan 11, 2022 | CHIEF BUSINESS OFFICER | 0.00 | $4.46 | -$25.13K | SELL-OPTIONS | 0.00% | 2.46K | Jan 10 | ||
Dec 14, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $6.23 | -$43.72K | SELL-OPTIONS | 0.00% | 2.46K | Dec 10 | ||
Dec 14, 2021 | CHIEF DEVELOPMENT OFFICER | -10.00K | $10.30 | -$103.00K | SELL | -1.34% | 737.75K | Dec 10 | ||
Dec 02, 2021 | DIRECTOR | 739.67K | $9.39 | $6.95M | BUY | ∞ | 471.35K | Nov 30 | ||
Dec 01, 2021 | CHIEF TECHNOLOGY OFFICER | -400.00 | $24.76 | -$9.90K | SELL | -0.03% | 1.17M | Nov 29 | ||
Nov 12, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $21.33 | -$306.95K | SELL-OPTIONS | 0.00% | 1.79K | Nov 10 | ||
Oct 21, 2021 | CHIEF TECHNOLOGY OFFICER | -12.00K | $27.98 | -$335.79K | SELL | -1.01% | 1.17M | Oct 19 | ||
Oct 15, 2021 | PRESIDENT AND CEO | 0.00 | $17.65 | -$128.24K | SELL-OPTIONS | 0.00% | 52.51K | Oct 14 | ||
Oct 12, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $14.98 | -$135.67K | SELL-OPTIONS | 0.00% | 1.79K | Oct 11 | ||
Sep 29, 2021 | PRESIDENT AND CEO | 0.00 | $17.45 | -$27.39K | SELL-OPTIONS | 0.00% | 52.51K | Sep 27 | ||
Sep 21, 2021 | CHIEF TECHNOLOGY OFFICER | -12.00K | $26.30 | -$315.60K | SELL | -1.00% | 1.19M | Sep 20 | ||
Sep 13, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $15.72 | -$143.44K | SELL-OPTIONS | 0.00% | 1.79K | Sep 10 | ||
Sep 09, 2021 | PRESIDENT AND CEO | 0.00 | $17.42 | -$76.67K | SELL-OPTIONS | 0.00% | 52.51K | Sep 07 - Sep 08 | ||
Sep 03, 2021 | PRESIDENT AND CEO | 0.00 | $17.44 | -$21.97K | SELL-OPTIONS | 0.00% | 54.27K | Sep 01 | ||
Aug 20, 2021 | CHIEF TECHNOLOGY OFFICER | -12.00K | $24.97 | -$299.64K | SELL | -0.99% | 1.20M | Aug 19 | ||
Aug 11, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $13.88 | -$124.14K | SELL-OPTIONS | 0.00% | 1.79K | Aug 10 | ||
Jul 21, 2021 | CHIEF TECHNOLOGY OFFICER | -12.00K | $25.10 | -$301.26K | SELL | -0.98% | 1.21M | Jul 19 - Jul 20 | ||
Jul 13, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $14.29 | -$128.35K | SELL-OPTIONS | 0.00% | 1.79K | Jul 12 | ||
Jun 21, 2021 | CHIEF TECHNOLOGY OFFICER | -12.00K | $24.80 | -$297.63K | SELL | -1.08% | 1.10M | Jun 18 | ||
Jun 11, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $15.89 | -$145.23K | SELL-OPTIONS | 0.00% | 1.79K | Jun 10 | ||
May 19, 2021 | CHIEF BUSINESS OFFICER | 0.00 | $13.11 | -$1.28M | SELL-OPTIONS | 0.00% | 1.79K | May 18 | ||
Nov 23, 2020 | — | 3.27M | $19.00 | $8.07M | DERIVATIVE CONVERSION | ∞ | 3.27M | Nov 23 | ||
Nov 23, 2020 | — | 3.74M | $19.00 | $22.04M | DERIVATIVE CONVERSION | ∞ | 1.16M | Nov 23 | ||
Nov 20, 2020 | — | 6.35M | $19.00 | $21.57M | DERIVATIVE CONVERSION | ∞ | 436.08K | Nov 19 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.